In a report released yesterday, Robbie Marcus from J.P. Morgan maintained a Buy rating on Boston Scientific (BSX – Research Report), with a price target of $48.00. The company's shares closed last Thursday at $41.16. According to TipRanks.com, Marcus is a 4-star analyst with an average return of 8.6% and a 49.3% success rate. Marcus covers the Healthcare sector, focusing on stocks such as Bausch + Lomb Corporation, Baxter International, and Edwards Lifesciences. Currently, the analyst consensus on Boston Scientific is a Strong Buy with an average price target of $47.18, representing a 17.2% upside.
https://www.tipranks.com/news/blurbs/j-p-morgan-maintains-a-buy-rating-on-boston-scientific-bsx?utm_source=advfn.com&utm_medium=referral
Boston Scientific (NYSE:BSX)
Historical Stock Chart
From Sep 2022 to Oct 2022 Click Here for more Boston Scientific Charts.
Boston Scientific (NYSE:BSX)
Historical Stock Chart
From Oct 2021 to Oct 2022 Click Here for more Boston Scientific Charts.